Vai al contenuto
Monitor Bandi SanitàAbruzzo · Basilicata · Campania · Molise · Puglia

← Tutti i bandi

Nuovo!ApertoEuropaHorizon Europe

Comparso nella raccolta del 9 ott 2026.

Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes (Horizon Europe)

Scadenza5 nov 2026 (tra 27 giorni)
Apertura domande6 mag 2026
Dotazione3 mln €
ProgrammaHorizon Europe (europeo)
Vale pertutte le Regioni coperte
Priorità / azioneCivil Security for Society 2026 · HORIZON-CL3-2026-01-FCT-06

Apri il bando sul sito ufficiale ↗ — fonte: Europa — Portale Funding & Tenders (EU4Health, Horizon Salute, Digital…)

Cosa puoi fare con questi fondi

Malattie rare, genetica e medicina di precisione — trovato: genetica

Puoi finanziare diagnosi genetiche, percorsi per malattie rare e ricerca su terapie avanzate e medicina di precisione

Enti più interessati: IRCCS e AOU, centri della rete malattie rare e delle reti europee (ERN)

Chi può partecipare

Non rivolto alle aziende sanitarie (testo rivolto a: "companies")

Di cosa si tratta (testo della fonte)

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Increased understanding of European policy makers, research community, biotech companies, and relevant security practitioners of the threat of bioterrorism and of synthetic biology, including a thorough lawful analysis of what needs to be monitored in this context, what needs to be regulated and how;Awareness raised within the related scientific community how research in synthetic biology can be used for malicious purposes. Scope:The rising threat of bioterrorism is driven by recent scientific advancements, notably by growing accessibility of synthetic biology, genetic engineering, related commercial services and public databases, which in turn enhance their obtainability to non-state actors and individuals with malicious intentions. The proliferation of do-it-yourself biohacking and community laboratories, including gene editing and sequencing technology, dropping costs of equipment and increased simplicity of use may inadvertently facilitate knowledge and skills dissemination about biological threats and open new pathways for bioterrorism. Challenges in detection, particularly the lengthy incubation periods of biological agents, underscore the urgent need for improved identification technologies to allow for timely intervention and reduce potential mass casualties, considering both characterization through advanced tools by expert labs and simple deployable methods. Given t

Esiti e storico

Nessun documento di esito collegato a questo bando (o non ancora pubblicato).

Storico partecipazioni (riservato)

Registro interno di cosa è successo a ciascuna azienda con ciascun bando. Visibile solo a redattori e amministratori.